Drugs Made In America Acquisition II Units (DMIIU) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	155.51K	235.47K	132.03K	112.23K
Operating expense	155.51K	1.05M	102.03K	112.23K
Total operating expenses	155.51K	1.05M	102.03K	112.23K
Operating income	-155.51K	-1.05M	-102.03K	-112.23K
Other non operating income	-	-	-	-
EBT including unusual items	-46.16K	4.33M	4.34M	4.40M
EBT excluding unusual items	-46.16K	3.78M	4.34M	4.40M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-46.16K	4.33M	4.34M	4.40M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	109.36K	4.82M	4.44M	4.51M
Interest expense	-	-	-	-
Net interest expenses	109.36K	4.82M	4.44M	4.51M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance